EUVIMEDEUVIMED entdecken
Crossref

Stabilin-1+ lipid-associated macrophages promote lung adenocarcinoma liver metastasis and osimertinib resistance through impairing macrophage phagocytosis via SIRPα-CD47 axis

Qi Wang, Jiuli Zhou, Xuefei Li, Chao Zhao, Lei Cheng, Li Wang, Jianing Chen, Chang Chen, Chunyu Li, Chunxia Su

Drug Resistance Updates · 2026-05 · 86 · 101379

DOI: 10.1016/j.drup.2026.101379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2026-05. Verfasst von Qi Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comprehensive Oncology Center, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shang…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Liver Neoplasms, Macrophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Shanghai Pulmonary Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Lipid-associated macrophages are a specific subpopulation of macrophages that play a crucial role in cancer progression and treatment resistance. However, the functional impact of lipid-associated macrophages in lung adenocarcinoma (LUAD) remains poorly understood. This study aims to investigate the role and underlying mechanisms of lipid-associated macrophages in LUAD liver metastasis and resistance to osimertinib, a third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). METHODS: Single-cell RNA sequencing (scRNA-seq) was performed on human lung tumor tissues from patients with primary LUAD and those with LUAD liver metastasis, which identified a novel subpopulation of stabilin-1 (STAB1)+ lipid-associated macrophages. The influence of STAB1+ lipid-associated macrophages on LUAD liver metastasis and osimertinib resistance was evaluated in vitro and in vivo. An in vitro co-culture system was established to investigate the interaction between LUAD cells and lipid-associated macrophages, and the mechanisms were analyzed by RNA-seq, Luminex multi-factor detection, Co-IP, in vivo, and rescue experiments. RESULTS: The subpopulation of STAB1+ lipid-associated macrophages was more abundant in liver metastatic LUAD tumors than in primary tumors. This lipid-associated macrophage subpopulation exhibited a stronger ability of lipid uptake from tumors and lipid droplet accumulation. We found that C-X-C motif ligand 12 (CXCL12) chemokine secreted by liver metastatic LUAD cells was responsible for recruiting circulating monocytes and subsequently inducing their differentiation into STAB1+ lipid-associated macrophages. STAB1 overexpression impaired the phagocytic ability of macrophage towards dying tumor cells by upregulating the signal regulatory protein α (SIRPα)-CD47 "don't eat me" signal. In tumor xenograft models, inhibition of STAB1+ lipid-associated macrophages effectively suppressed LUAD osimertinib resistance and liver metastasis. CONCLUSIONS: Our study demonstrates that STAB1+ lipid-associated macrophages contribute to LUAD liver metastasis and osimertinib resistance by impairing macrophage phagocytosis via the SIRPα-CD47 axis, opening a potential avenue for future research and treatment development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsLiver NeoplasmsMacrophagesDrug Resistance, NeoplasmCell Adhesion Molecules, NeuronalAniline CompoundsHumansPhagocytosisAnimalsReceptors, ImmunologicMicePyrimidinesCell Line, TumorProtein Kinase InhibitorsIndolesMaleFemaleReceptors, Lymphocyte Homing

Stichwörter der Autor:innen

SIRPα-CD47 axisSTAB1lipid-associated macrophageslung adenocarcinomaosimertinib resistancetyrosine kinase inhibitor (TKI)

Substanzen

STAB1 protein, humanReceptors, ImmunologicCell Adhesion Molecules, NeuronalAniline CompoundsPyrimidinesProtein Kinase InhibitorsIndolesStab1 protein, mouseReceptors, Lymphocyte Homing

Autor:innen und Institutionen

  • Department of Comprehensive Oncology Center, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai 200433, China.
  • Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200123, China.
  • Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai 200433, China.
  • Tongji University, Tongji University Medical School Cancer Institute, Shanghai 200433, China.
  • Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China. Electronic address: changchenc@tongji.edu.cn.
  • Department of Integrated Traditional Chinese and Western Medicine, International Medical School, Tianjin Medical University, Tianjin 300070, China. Electronic address: lichunyu@tmu.edu.cn.

Förderung

  • National Key Research and Development Program of China
  • Shanghai Pulmonary Hospital

Zitieren

APA

Wang, Q., Zhou, J., Li, X., Zhao, C., Cheng, L., Wang, L., Chen, J., Chen, C., Li, C., & Su, C. (2026). Stabilin-1+ lipid-associated macrophages promote lung adenocarcinoma liver metastasis and osimertinib resistance through impairing macrophage phagocytosis via SIRPα-CD47 axis. Drug Resistance Updates, 86, 101379. https://doi.org/10.1016/j.drup.2026.101379

Vancouver

Wang Q, Zhou J, Li X, Zhao C, Cheng L, Wang L, et al. Stabilin-1+ lipid-associated macrophages promote lung adenocarcinoma liver metastasis and osimertinib resistance through impairing macrophage phagocytosis via SIRPα-CD47 axis. Drug Resistance Updates. 2026;86:101379. doi:10.1016/j.drup.2026.101379

BibTeX
@article{Wang2026,
  author = {Wang, Qi and Zhou, Jiuli and Li, Xuefei and Zhao, Chao and Cheng, Lei and Wang, Li and Chen, Jianing and Chen, Chang and Li, Chunyu and Su, Chunxia},
  title = {Stabilin-1+ lipid-associated macrophages promote lung adenocarcinoma liver metastasis and osimertinib resistance through impairing macrophage phagocytosis via SIRPα-CD47 axis},
  journal = {Drug Resistance Updates},
  year = {2026},
  volume = {86},
  pages = {101379},
  doi = {10.1016/j.drup.2026.101379}
}
Kostenlos starten →